Novel oxazolidinone derivatives with a difluorophenyl moiety, represented by Chemical Formula 1, pharmaceutically acceptable salts thereof, a preparation method thereof, and a pharmaceutical composition containing the same as an active ingredient are provided. (justia.com)
The present invention relates to novel oxazolidinone derivatives with a difluorophenyl moiety, pharmaceutically acceptable salts thereof, a method for preparing the same, and an antibiotic composition containing the same as an active ingredient. (justia.com)
Specific methods encompass the administration of an immunomodulatory compound, or a pharmaceutically acceptable salt, solvate, hydrate, stereoisomer, clathrate, or prodrug thereof, alone or in combination with a second active agent, and/or the transplantation of blood or cells. (patsnap.com)
The present invention further discloses a method for delivering a pharmaceutical composition to a patient in need thereof, comprising: administering to said patient a pharmaceutical composition in unit dose form comprising naproxen, or a pharmaceutically acceptable salt thereof, and lansoprazole, or a pharmaceutically acceptable salt thereof. (quickcompany.in)
piperidin-l-yl)prop-2-en-l-one and pharmaceutically acceptable salts, solvates and pharmaceutical compositions thereof. (drugapprovalsint.com)
or a pharmaceutically acceptable solvate thereof. (sumobrain.com)
Salts1
Published International Patent applications WO 97/19927, WO 97/19928, WO 99/14196 and WO 02/094187 disclose additional therapeutic utilities for talnetant, pharmaceutically acceptable salts and processes for its preparation. (patentsencyclopedia.com)
Sodium3
Their industrial-scale preparation has been designed and uses sodium hydroxide as the base in a very concentrated aqueous CD solution [3] . (beilstein-journals.org)
For aqueous formulations of solutions which are to be converted into inhalable aerosols using the inhaler described above, the specification favours a minimum concentration of sodium edetate of 50 mg/100 ml, in order to reduce the incidence of spray anomalies. (allindianpatents.com)
The [ 11 C]1-(4-(((6-amino-5-(4-phenoxyphenyl)pyrimidin-4-yl)amino)methyl)piperidin-1-yl)prop-2-en-1-one ([ 11 C]evobrutinib) was isolated between the 15.5 and 18 min mark of the chromatogram and this sample was collected into a dilution flask that contained 50 ml of a 2 mg/ml sodium ascorbate aqueous solution. (drugapprovalsint.com)
Salt1
The present invention relates to a propellant-free aerosol formulation of a pharmaceutically acceptable salt of tiotropium dissolved in water. (allindianpatents.com)
Compound1
sets from the compound will carry congestive to muscles to excrete and provide acceptable and side implants to cause the resting and uncertain failure of mechanisms. (siriuspixels.com)
Stable3
These are the oldest and most commonly used CDPs [1] , more so than the so-called "nanosponges" [2] , as well as being more chemically stable in both aqueous and alcoholic media. (beilstein-journals.org)
There is widespread interest of using liposomes as drug carriers, which requires pharmaceutically acceptable procedures for scaling up to larger batch sizes, stable and economically feasible. (biomedcentral.com)
acceptable solvent or solvent combination that is appropriate for freeze-drying on the basis of its ability to (1) solubilize hydrophobic drugs,(2) provide a stable environment for water-sensitive compounds, (3) Materials be rapidly and completely removed from the product under vacuum,and (4) produce cakes that are readily reconstituted. (aboutdrugspdf.com)
Solution1
13(1): 155-157, PMID 31031497 Evaluation of Skin Penetration of Diclofenac from a Novel Topical Non Aqueous Solution: A Comparative Bioavailability Study, Manish Nivsarkar, Sanjaykumar Maroo, Ketan R Patel, Dixit D Patel, ISSN: 0975-8232, 2017 Talukdar, Tapash (8 September 2008). (wikipedia.org)
Medium2
In basic aqueous medium, the high reactivity and low water-miscibility of 1,2-propylene oxide make the formation of (oligo)propylene glycol (oligo-PGs) unavoidable. (beilstein-journals.org)
It is thus highly soluble in aqueous medium over the pH range 1-6.8. (who.int)
Drug1
Floating drug delivery system: An innovative acceptable approach in gastroretentive drug delivery. (rjpdft.com)
Carrier7
1. A pharmaceutical formulation comprising as active ingredient, 3'-azido-3'-deoxythymidine, and a pharmaceutically acceptable carrier therefor. (gc.ca)
3. A formulation according to claim 1, wherein said carrier is non-aqueous. (gc.ca)
21. A pharmaceutical formulation for use in the treatment or prophylaxis of human retrovirus infections comprising an effective amount of 3'-azido-3'-deoxythy midine in association with a pharmaceutically accept- able carrier. (gc.ca)
4. A pharmaceutical composition comprising an effective amount of a compound according to claim 1 and a pharmaceutically acceptable carrier or excipient. (everypatent.com)
12. The immunogenic composition of claim 11, further comprising a pharmaceutically acceptable carrier. (patentsencyclopedia.com)
13. The immunogenic composition of claim 12, wherein the pharmaceutically acceptable carrier is an adjuvant. (patentsencyclopedia.com)
19. The immunogenic composition of claim 18, further comprising a pharmaceutically acceptable carrier. (patentsencyclopedia.com)
Suspensions3
Injectable suspensions are heterogeneous systems that typically consist of a solid phase dispersed in a liquid phase, the liquid phase being aqueous or nonaqueous. (justia.com)
Recently several long acting injectables have been developed as aqueous suspensions and nanosuspensions. (ddfsummit.com)
Long acting injectables have been developed traditionally using a variety of different approaches such as oily solution, aqueous suspensions, gels, nanosuspensions and microspheres. (ddfsummit.com)
Water soluble3
Formally, silica (SiO 2 ) is a silicic acid anhydride of monomeric ortho-silicic acid (H 4 SiO 4 ), which is water soluble and stable in highly diluted aqueous solutions. (biomedcentral.com)
These are water soluble, formed in reversible equilibrium reactions from H 4 SiO 4 and stable in diluted aqueous solutions. (biomedcentral.com)
The poor solubility and low dissolution rate of poorly water soluble drugs in the aqueous gastro-intestinal fluids often cause insufficient bioavailability. (ijpsr.com)
Composition2
Inventor of the asserted patents overcame this problem by providing stable non-aqueous bendamustine composition which contains appropriate quantities of PG & PEG solvents. (pharmaipcircle.com)
La composition peut comprendre, en outre, au maximum 7 unités de dosage quotidiennes ne renfermant pas d'agent actif ou contenant uniquement de l'éthinylestradiol. (gc.ca)
Formulation1
Olthoff (1983) - discloses non-aqueous, ready to use bendamustine formulation (25 and 100 mg/mL) in polyols such as PG & PEG. (pharmaipcircle.com)
Injection2
The injectable compositions include microparticles suspended in an aqueous injection vehicle having a viscosity of at least 20 cp at 20° C. The increased viscosity of the injection vehicle that constitutes the fluid phase of the suspension significantly reduces in vivo injectability failures. (justia.com)
The injectable compositions can be made by mixing dry microparticles with an aqueous injection vehicle to form a suspension, and then mixing the suspension with a viscosity enhancing agent to increase the viscosity of the fluid phase of the suspension to the desired level for improved injectability. (justia.com)
Form1
Most of the silica in aqueous systems and oceans is available in the form of H 4 SiO 4 , which makes it an important compound in environmental silicon-chemistry and biology [ 3 ]. (biomedcentral.com)
Exist2
Moreover, several "lower" hydrated forms of ortho-silicic acid exist in aqueous solutions as well including meta-silicic acid (H 2 SiO 3 or lower oligomers like di-silicic (H 2 Si 2 O 5 ) and tri-silicic acids (H 2 Si 3 O 7 ) including their hydrated forms pentahydro-silicic (H 10 Si 2 O 9 ), and pyro-silicic acids (H 6 Si 2 O 7 ) [ 1 ]. (biomedcentral.com)
Whether you exist used the specificity or pharmaceutically, if you suffer your prevalent and hemodynamic factors biologically brochures will do Coronary years that produce currently for them. (augenta.net)